ADUS
Get informed when a big investor buys or sells
+ FollowUndervalued by 105.8% based on the discounted cash flow analysis.
| Market cap | $1.76 Billion |
|---|---|
| Enterprise Value | $1.79 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $5.19 |
| Beta | 0.9 |
| Outstanding Shares | 18,486,000 |
| P/E Ratio | 17.42 |
|---|---|
| PEG | 96.26 |
| Price to Sales | 1.23 |
| Price to Book Ratio | 1.6 |
| Enterprise Value to Revenue | 1.24 |
| Enterprise Value to EBIT | 12.67 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | 0.12 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 12.89% |
|---|---|
| Total Calls | 22,300▲ 14.95% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 104.36%▲ 1.65% |
|---|---|
| Total Invested | $1.80B▼ 10.98% |
| Investors Holding | 300▼ 10.00% |
No data
Jurisdiction over Medicare and Medicaid, which provide the vast majority of Addus's revenue; directly controls reimbursement rates.
Authorizes the specific dollar amounts for health programs; determines the actual cash flow into the state and federal programs Addus bills.
Regulates labor laws and caregiver standards; labor costs and nursing regulations are critical drivers of Addus's profitability.
Directly investigates long-term care and home-based services; hearings create significant headline risk and regulatory pressure for Addus.